samedan logo
 
 
 
spacer
home > pmps > winter 2001 > digital printing for pharmaceutical packaging - a customer's perspective
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Digital Printing for Pharmaceutical Packaging - A Customer's Perspective

As digital printing becomes a more viable option for packaging, printing vendors are looking to the pharmaceutical industry as a lucrative market. There are several reasons why digital printing is suitable for pharmaceutical packaging:

The option of quick turnaround for printed materials is
especially attractive in an industry which is under increasing
pressure to bring products to launch

Frequent changes to packaging make any options which
reduce the inventory of printed materials very advantageous

Rapid safety changes are often necessary for
pharmaceutical products

While the cost of printed materials is not a major portion
of the cost of the product for large orders of pharmaceutical
products, this is not always true for short run, small volume
products.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Susan B. McNeely, Associate Engineering Consultant at Eli Lilly and Company in the US
Susan McNeely is a member of Eli Lilly and Company's corporate team, which provides technical support to Lilly packaging sites worldwide.
She is a Chemist by training and her previous assignments at Lilly include printed packaging development, pharmaceutical product development and quality assurance. Prior to joining Lilly, Susan worked at RCA and the University of Cincinnati Medical Center.

spacer
Susan B. McNeely
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

SHIONOGI LAUNCHES FETCROJAŽ (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH LIMITED TREATMENT OPTIONS


More info >>

White Papers

The Emerging Use of Social Media in Orphan Disease Drug Research

Worldwide Clinical Trials Ltd

The use of various social media platforms, such as Twitter, Instagram, Facebook, and LinkedIn, for dissemination of clinical trial information has created a cornucopia of possibilities enabling clinical trial performance. Characterized by a people-to-people immediacy, social media permits extraordinarily adaptive modification of study information in real-time, and it does so in a highly targeted fashion.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement